Raffaele Colombo, Principal Scientist and Group Lead, Medicinal Chemistry at Zymeworks Inc., made the following post on Twitter:
“Remember the days of meeting handouts? And having all the ADCs summarized in one page?
The photo is from a 2017 handout: How many ADCs got approved? How many discontinued? How many still in development?
Fast forward: 13 ADCs approved & >170 currently in development.”
Source: Raffaele Colombo/Twitter